SK281226B6 - Prednizolónové deriváty, liečivá s ich obsahom a ich použitie - Google Patents

Prednizolónové deriváty, liečivá s ich obsahom a ich použitie Download PDF

Info

Publication number
SK281226B6
SK281226B6 SK1223-95A SK122395A SK281226B6 SK 281226 B6 SK281226 B6 SK 281226B6 SK 122395 A SK122395 A SK 122395A SK 281226 B6 SK281226 B6 SK 281226B6
Authority
SK
Slovakia
Prior art keywords
mmol
compounds
epimer
formula
compound
Prior art date
Application number
SK1223-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK122395A3 (en
Inventor
Hermann Amschler
Dieter Flockerzi
Richard Riedel
Stefan Postius
Michael Stoeck
Rolf Beume
Karl Zech
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of SK122395A3 publication Critical patent/SK122395A3/sk
Publication of SK281226B6 publication Critical patent/SK281226B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1223-95A 1993-04-02 1994-03-31 Prednizolónové deriváty, liečivá s ich obsahom a ich použitie SK281226B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH102393 1993-04-02
PCT/EP1994/001015 WO1994022899A1 (de) 1993-04-02 1994-03-31 Neue prednisolonderivate

Publications (2)

Publication Number Publication Date
SK122395A3 SK122395A3 (en) 1996-01-10
SK281226B6 true SK281226B6 (sk) 2001-01-18

Family

ID=4200650

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1223-95A SK281226B6 (sk) 1993-04-02 1994-03-31 Prednizolónové deriváty, liečivá s ich obsahom a ich použitie

Country Status (21)

Country Link
US (1) US5733901A (es)
EP (1) EP0701565B1 (es)
JP (1) JP3333210B2 (es)
KR (1) KR100330941B1 (es)
CN (1) CN1062869C (es)
AT (1) ATE172739T1 (es)
AU (1) AU683463B2 (es)
BG (1) BG62491B1 (es)
CZ (1) CZ287877B6 (es)
DE (1) DE59407183D1 (es)
DK (1) DK0701565T3 (es)
ES (1) ES2124884T3 (es)
FI (1) FI113543B (es)
HU (1) HU220868B1 (es)
NO (1) NO305990B1 (es)
NZ (1) NZ265054A (es)
PL (1) PL179489B1 (es)
RU (1) RU2132854C1 (es)
SK (1) SK281226B6 (es)
UA (1) UA45311C2 (es)
WO (1) WO1994022899A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
US7468433B2 (en) * 2000-11-10 2008-12-23 Nycomed Gmbh Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
PL373433A1 (en) * 2002-08-30 2005-08-22 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
ATE405275T1 (de) * 2002-12-12 2008-09-15 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
CA2528479A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
ATE476185T1 (de) * 2003-09-15 2010-08-15 Nycomed Gmbh Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
CA2538419C (en) * 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1796679A1 (en) * 2004-09-10 2007-06-20 Altana Pharma AG Ciclesonide and syk inhibitor combination and methods of use thereof
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
AU2006259604A1 (en) * 2005-06-14 2006-12-28 Gilead Sciences, Inc. Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction
WO2007054974A2 (en) * 2005-09-28 2007-05-18 Arch Pharmalab Limited A green chemistry process for the preparation of pregnadiene esters
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
AU2007298770B2 (en) * 2006-09-19 2013-01-31 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
CA2714653A1 (en) * 2008-03-13 2009-09-17 Farmabios S.P.A. Process for the preparation of pregnane derivatives
ITMI20080645A1 (it) * 2008-04-11 2009-10-12 Ind Chimica Srl Procedimento per la preparazione di budesonide
ES2471145T3 (es) 2009-03-09 2014-06-25 Mikasa Seiyaku Co,. Ltd. Compuesto esteroide
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
US9109005B2 (en) * 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
CN103421075B (zh) * 2012-05-16 2017-07-28 上海特化医药科技有限公司 孕烷衍生物16,17‑缩醛(酮)的制备方法
PL3464318T3 (pl) 2016-06-02 2021-11-08 Abbvie Inc. Agonista receptora glukokortykoidowego i jego immunokoniugaty
US10772970B2 (en) 2017-12-01 2020-09-15 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.

Also Published As

Publication number Publication date
ATE172739T1 (de) 1998-11-15
CN1062869C (zh) 2001-03-07
AU683463B2 (en) 1997-11-13
PL179489B1 (pl) 2000-09-29
DE59407183D1 (de) 1998-12-03
KR100330941B1 (ko) 2002-10-12
BG100032A (bg) 1996-05-31
JPH08508278A (ja) 1996-09-03
DK0701565T3 (da) 1999-07-12
ES2124884T3 (es) 1999-02-16
CZ287877B6 (cs) 2001-03-14
US5733901A (en) 1998-03-31
EP0701565B1 (de) 1998-10-28
WO1994022899A1 (de) 1994-10-13
NO953861D0 (no) 1995-09-29
JP3333210B2 (ja) 2002-10-15
SK122395A3 (en) 1996-01-10
NO305990B1 (no) 1999-08-30
FI113543B (fi) 2004-05-14
CN1120339A (zh) 1996-04-10
PL311474A1 (en) 1996-02-19
EP0701565A1 (de) 1996-03-20
NZ265054A (en) 1997-08-22
HU9502819D0 (en) 1995-11-28
FI954579A (fi) 1995-09-27
RU2132854C1 (ru) 1999-07-10
BG62491B1 (bg) 1999-12-30
HU220868B1 (en) 2002-06-29
AU6538194A (en) 1994-10-24
NO953861L (no) 1995-09-29
CZ252995A3 (en) 1996-01-17
HUT72594A (en) 1996-05-28
UA45311C2 (uk) 2002-04-15
FI954579A0 (fi) 1995-09-27

Similar Documents

Publication Publication Date Title
SK281226B6 (sk) Prednizolónové deriváty, liečivá s ich obsahom a ich použitie
US5674861A (en) Fluorinated steroids
BG60799B2 (bg) Ароматни хетероциклени стероидни естери,получаването им и фармацевтични състави,които ги съдържат
CZ292860B6 (cs) Deriváty androstenu a farmaceutický prostředek obsahující tyto deriváty
DD227966A5 (de) Verfahren zur herstellung neuer carbonsaeureester
CH648856A5 (de) Soft-steroide mit anti-inflammatorischer aktivitaet.
US4910192A (en) Topically active steroidal anti-inflammatory agents
NZ199141A (en) 16,17-acetals of 16alpha-hydroxycortisol and pharmaceutical compositions
US4427671A (en) Steroids esterified in position 17 and thioesterified in position 21, a process for preparing them and their use as medicaments
CH644614A5 (de) 17-alpha-acyloxy-5-beta- und 17-alpha-acyloxy-5-alpha-corticoide.
US5021408A (en) Hydrocortisone-17-oxo-21-thioesters, their preparation and their uses as medicaments
JPS6214557B2 (es)
US4107161A (en) Bis(triamcinolone acetonide)-4,4'-methylenebis-(3-methoxy-2-naphthoate)
CA2159627C (en) Novel prednisolone derivatives
DE2340656A1 (de) Steroidverbindungen
US4185101A (en) 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
EP0320253A1 (en) 21-Alkoxysteroid compounds
GB1594852A (en) Derivatives of 9-chloroprednisolone
EP0193871A2 (en) 2-Oxa- or aza-pregnane compounds
JPS6112698A (ja) 17‐(置換チオ)‐17‐(置換ジチオ)アンドロステン類
JPS58103399A (ja) 6α−メチルプレドニゾロン17−エステル化合物
JPS604198B2 (ja) 3,20―ジオキソ―7α―ハロ―4―プレグネン類または―1.4―プレグナジエン類、およびその製造方法ならびに該化合物を含有する抗炎症剤
CS244662B2 (cs) Způsob výroby nových derivátů 9-chlorprednisolonu
DE2809732A1 (de) Neue derivate des 9-fluorprednisolons

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: TAKEDA GMBH, KONSTANZ, DE

Effective date: 20130725

MK4A Patent expired

Expiry date: 20140331